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Abstract
A subline highly resistant to Adriamycin (SBC-3/ADM100) was isolated in vitro from the
human small cell lung cancer cell line, SBC-3, by culturing in progressively higher concen-
trations of Adriamycin. The SBC-3/ADM100 cells were 106-fold more resistant to the drug
than the parent cells in an inhibitory concentration of 50% determined by the MTT assay. The
population-doubling time was much longer in SBC-3/ADM100 than in the parent cells. North-
ern blot hybridization revealed marked overexpression of the MDR1 mRNA in the resistant cells.
P-glycoprotein overexpression and a decrease in intracellular accumulation of Adriamycin were
demonstrated in SBC-3/ADM100, indicating that outward drug transport was the major mecha-
nism of resistance in this subline. Additionally, a significant elevation of the intracellular glu-
tathione content coupled with the glutathione S-transferase (GST) pi level and a decrease in DNA
topoisomerase II (Topo II) activity were noted in this resistant subline. These results indicate that
the mechanism of resistance to Adriamycin is multifactorial; involving altered growth character-
istics, an enhanced outward transport, enhanced drug detoxification process, and decreased target
enzyme activity. The resistant subline will serve as a useful tool in the search for ways to overcome
drug resistance.
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